MRSA

MRSA is now the pathogen of a global health problem. These are Staphylococcus aureus strains that are resistant to oxacillin, nafcillin, and methicillin. They are also resistant to all beta-lactam drugs. It can cause a variety of problems, from skin infections and sepsis to pneumonia and various types of bloodstream infections. It is commonly seen in people in medical facilities such as dialysis centers. The current arsenal of antibiotics available for the treatment of MRSA includes topical agents and a limited number of oral agents.

·         Community-acquired MRSA (CA-MRSA)

·         Healthcare-associated MRSA (HA-MRSA)

·         CA-MRSA virulence-related factors

·         Antibiotic-resistant linezolid

·         Pneumonia (HAP/VAP)

·         Chronic osteomyelitis (COM)

·         Skin and soft tissue infections

  • Chronic osteomyelitis
  • Skin and soft tissue infections

Related Conference of MRSA

November 21-22, 2024

7th Pathology and Infectious Disease Conference

Dubai, UAE
November 28-29, 2024

20th World Congress on Infection Prevention and Control

Paris, France
March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands

MRSA Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in